
Truveris
Truveris is a technology company driving transparency, access and lower costs across the prescription drug ecosystem..
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
* | $15.0m Valuation: $125m | Series E | |
Total Funding | 000k |
USD | 2017 |
---|---|
Revenues | 0000 |
EBITDA | 0000 |
Profit | 0000 |
EV | 0000 |
EV / revenue | 00.0x |
EV / EBITDA | 00.0x |
R&D budget | 0000 |
Source: Company filings or news article
Related Content
Truveris is a technology and data analytics company that focuses on the prescription drug industry. The company operates within the pharmacy supply chain, which is often complex and difficult to manage. Truveris serves a variety of clients, including payers (those who finance or reimburse the cost of health services), brokers (intermediaries who help negotiate drug prices), and manufacturers (companies that produce pharmaceuticals).
The core mission of Truveris is to provide clear and confident insights into pharmacy benefits, which in turn supports better employee health, productivity, and satisfaction. They achieve this by offering a range of solutions designed to navigate the evolving complexities of the pharmacy landscape. For example, they provide custom-branded pharmacy practice programs that help benefits advisors grow their business by leveraging Truveris' technology and insights.
Truveris makes money through a business model that involves selling its technology solutions and data analytics services to its clients. These services include cost containment solutions, expert clinical guidance, and strategies to help clients manage their pharmacy benefits more effectively. Additionally, Truveris builds patient access programs that help pharmaceutical brands reach patients in the most impactful ways, predicting market shifts and delivering insights for sustainable program design.
The company also plays a crucial role in responding to regulatory challenges, such as the FDA's recall of certain metformin ER products due to contamination concerns. By staying ahead of such issues, Truveris helps its clients adapt to new norms and solve future problems.
In summary, Truveris is a key player in the pharmacy benefits market, providing technology and data-driven solutions to help clients manage their pharmacy benefits more effectively.
Keywords: Pharmacy, Data Analytics, Technology, Benefits, Payers, Brokers, Manufacturers, Cost Containment, Clinical Guidance, Patient Access.